Mandelic Acid-Tranexamic Acid Complex Doubles Pigmentation Improvement in 2 Weeks
Mandelic acid is an alpha hydroxy acid (AHA) derived from almonds (from the German Mandel). At 152 Da, it is the largest molecule in the AHA family, considerably heavier than glycolic acid (76 Da). That size means slower penetration, gentler exfoliation, and a better tolerance profile for oilier or more reactive skin. For years it has been used in post-acne pigmentation management and skin tone refinement as a milder alternative to stronger AHAs.
A research team at LG Household & Health Care (Seoul) published findings in Skin Research and Technology in September 2025 showing what happens when mandelic acid is not used alone but paired with tranexamic acid (TXA) in an ion-pairing complex, creating a combined molecule that penetrates more efficiently than either ingredient separately.
The Ion-Pairing Mechanism
Tranexamic acid is water-soluble, which limits its penetration through the lipid-rich stratum corneum. Mandelic acid carries an anionic charge that can form an ion pair with cationic TXA, producing a neutral complex with a measured surface charge of -3.3 mV. This neutralization significantly improves affinity for the skin’s lipid barrier.
- Penetration at 1 hour: TXA-MA complex was 2.24 times faster than TXA alone
- Maintained approximately 1.4 times faster penetration from 2 to 6 hours
Faster penetration means more active ingredient reaching melanocytes, the cells responsible for pigment production, in less time.
Clinical Results at 2 and 4 Weeks
- Participants: 32 female subjects, mean age 45.8 years
- Design: Split-face comparison (TXA-MA complex on one side, TXA alone on the other)
- Duration: 4 weeks (October–November 2024)
Pigmentation improvement rates:
| Timepoint | TXA-MA Complex | TXA Alone | Significance |
|---|---|---|---|
| 2 weeks | 15.42% | 7.09% | p < 0.001 |
| 4 weeks | 10.75% | 7.75% | Significant |
At two weeks, the complex showed more than twice the improvement of TXA alone. Both groups continued to improve through week four, but the complex retained its early advantage.
In cell studies, the complex outperformed TXA alone in suppressing all tested inflammatory markers: IL-1α, IL-6, IL-8, and COX-2. Since hyperpigmentation is frequently triggered or worsened by inflammation, this anti-inflammatory advantage compounds the brightening effect.
How Mandelic Acid Contributes to Pigmentation Control
Mandelic acid works through two distinct mechanisms relevant to pigmentation:
- Surface exfoliation: Accelerates corneocyte turnover, progressively shedding pigment-loaded surface cells. The large molecule size makes this process more gradual and less irritating than glycolic acid.
- Complementary brightening: While mandelic acid is not a potent tyrosinase inhibitor on its own, it supports TXA’s melanin-blocking action by improving delivery and adding anti-inflammatory activity.
In this combination, mandelic acid serves as both carrier and co-active, facilitating TXA’s reach while contributing its own exfoliating benefit.
Separate Clinical: 30% Mandelic Acid Peel for Dark Circles
A separate study from Amaltas Institute of Medical Sciences (India), published October 2025, evaluated 30% mandelic acid peels applied three times at two-week intervals for periorbital melanosis (dark circles) in 61 patients. Results: 83.9% patient satisfaction. Side effects included irritation in 28.6% and exfoliation in 5.7%. High-concentration peels should be administered under professional supervision.
Choosing the Right Concentration
- Daily routine (5–10%): Gentle exfoliation, acne-prone or oily skin, introductory AHA
- Intensive use (10–15%): Weekly application, more visible exfoliation
- Combination products: Look for niacinamide or tranexamic acid co-formulations for enhanced brightening
- Essential pairing: Sunscreen is non-negotiable after AHA use. Freshly exfoliated skin is more vulnerable to UV-induced pigmentation.
Source
Skin Research and Technology - TXA-Mandelic Acid Ion-Pairing Complex for Pigmentation (2025)